Catheter Ablation Versus Radio-Ablation for Ventricular Tachycardia: a Randomized Controlled Trial

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 244 participants.

Also called NCT05047198

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 244 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05047198
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05047198. Randomized; no masking; primary purpose treatment. Start 2022-12-06 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Catheter Ablation Versus Radio-Ablation for Ventricular Tachycardia: a Randomized Controlled Trial
Acronym
CARA-VT RCT
Condition
Ventricular Tachycardia
Intervention (Procedure)
Control - Catheter Ablation for VT
Intervention (Procedure)
Treatment - Non-Invasive Radio Ablation for VT
Lead sponsor
Ottawa Heart Institute Research Corporation (class: other)

Record details

Record id
cardio:ct-nct05047198
Content hash
050830ceed5eaa4e85fdc67e7eae3028c96e3a99b1e36ab7c83438e26d541bf5